Chiropractors in Marion, IN Accepting Medicare

10 Chiropractors found. Showing 1 - 10

Clear Chiropractic Marion Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1105 N Western Ave, Marion, IN 46952 Phone: 765-664-2479    Fax: 765-662-1625

Dr. Tyler Maitland Graham Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2716 S Western Ave, Marion, IN 46953 Phone: 574-274-8960    Fax: 765-662-0101

Dr. David James Aaron, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 1700 E 38th St, Marion, IN 46953 Phone: 765-661-9764

Dr. Jessica Robin Gudgel, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1114 N Western Ave, Marion, IN 46952 Phone: 765-662-0395    Fax: 765-662-0396

Dr. Thomas Lee Arnold, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1331 W 35th St, Marion, IN 46953 Phone: 765-674-1111    Fax: 765-674-1166

Jacob M Schlosser, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 600 N River Dr, Marion, IN 46952 Phone: 765-664-2479

Arnold Chiropractic P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 1331 W 35th St, Marion, IN 46953 Phone: 765-674-1111    Fax: 765-674-1166

Lundius Family Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1114 N Western Ave, Marion, IN 46952 Phone: 765-662-0395    Fax: 765-662-0396

Lutes Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 324 S Boots St, Marion, IN 46952 Phone: 765-662-7362    Fax: 765-662-8494

Dr. Larry Allen Lutes, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 324 S Boots St, Marion, IN 46952 Phone: 765-662-7362    Fax: 765-662-8494

News Archive

FDLI conference to discuss IOM study on 510(k) Clearance Process

On the heels of the release of the highly anticipated Institute of Medicine (IOM) report, Public Health Effectiveness of the FDA 510(k) Clearance Process, The Food and Drug Law Institute (FDLI) is holding a "Dialogue" on the report August 4 in Washington, D.C.

Altheos to fund development of ATS907 Rho-kinase inhibitor with completed $20M Series A financing

Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor Altheos licensed from Japanese pharmaceutical company Asahi Kasei Pharma. The license also includes a series of highly active compounds (AK138 series) specifically for topical treatment for glaucoma.

Study shows the need to refine COVID-19 testing criteria to include children with GI symptoms

Over 1,000 children from Northern Ireland, Scotland, England and Wales, known as 'COVID Warriors' have had their antibodies measured in the UK-wide trial called 'Seroprevalence of SARS-Cov-2 infection in healthy children'.

New microfluidic device can rapidly isolate target cells

Separating complex mixtures of cells, such as those found in a blood sample, can offer valuable information for diagnosing and treating disease. However, it may be necessary to search through billions of other cells to collect rare cells such as tumor cells, stem cells or fetal cells. "You're basically looking for a needle in a haystack," says Sukant Mittal, a graduate student in the Harvard-MIT Division of Health Sciences and Technology.

Read more Medical News

› Verified 2 days ago